Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 770

1.

The LipiDiDiet trial: what does it add to the current evidence for Fortasyn Connect in early Alzheimer's disease?

Rasmussen J.

Clin Interv Aging. 2019 Aug 15;14:1481-1492. doi: 10.2147/CIA.S211739. eCollection 2019.

2.

Effects of oily fish intake on cardiometabolic markers in healthy 8- to 9-y-old children: the FiSK Junior randomized trial.

Vuholm S, Rantanen JM, Teisen MN, Stark KD, Mølgaard C, Christensen JH, Lauritzen L, Damsgaard CT.

Am J Clin Nutr. 2019 Dec 1;110(6):1296-1305. doi: 10.1093/ajcn/nqz233.

PMID:
31595295
3.

EPA and DHA have divergent effects on serum triglycerides and lipogenesis, but similar effects on lipoprotein lipase activity: a randomized controlled trial.

Klingel SL, Metherel AH, Irfan M, Rajna A, Chabowski A, Bazinet RP, Mutch DM.

Am J Clin Nutr. 2019 Dec 1;110(6):1502-1509. doi: 10.1093/ajcn/nqz234.

PMID:
31535138
4.

Genetic profiling of fatty acid desaturase polymorphisms identifies patients who may benefit from high-dose omega-3 fatty acids in cardiac remodeling after acute myocardial infarction-Post-hoc analysis from the OMEGA-REMODEL randomized controlled trial.

Kwong RY, Heydari B, Ge Y, Abdullah S, Fujikura K, Kaneko K, Harris WS, Jerosch-Herold M, Antman EM, Seidman JG, Pfeffer MA.

PLoS One. 2019 Sep 18;14(9):e0222061. doi: 10.1371/journal.pone.0222061. eCollection 2019.

5.

A Randomized Trial of Prenatal n-3 Fatty Acid Supplementation and Preterm Delivery.

Makrides M, Best K, Yelland L, McPhee A, Zhou S, Quinlivan J, Dodd J, Atkinson E, Safa H, van Dam J, Khot N, Dekker G, Skubisz M, Anderson A, Kean B, Bowman A, McCallum C, Cashman K, Gibson R.

N Engl J Med. 2019 Sep 12;381(11):1035-1045. doi: 10.1056/NEJMoa1816832.

PMID:
31509674
6.
7.

No CFH or ARMS2 Interaction with Omega-3 Fatty Acids, Low versus High Zinc, or β-Carotene versus Lutein and Zeaxanthin on Progression of Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report No. 18.

van Asten F, Chiu CY, Agrón E, Clemons TE, Ratnapriya R, Swaroop A, Klein ML, Fan R, Chew EY; Age-Related Eye Disease Study 2 Research Group.

Ophthalmology. 2019 Nov;126(11):1541-1548. doi: 10.1016/j.ophtha.2019.06.004. Epub 2019 Jun 12.

PMID:
31358387
8.

Effect of rosuvastatin and eicosapentaenoic acid on neoatherosclerosis: the LINK-IT Trial.

Kuroda K, Otake H, Shinohara M, Kuroda M, Tsuda S, Toba T, Nagano Y, Toh R, Ishida T, Shinke T, Hirata KI.

EuroIntervention. 2019 Dec 20;15(12):e1099-e1106. doi: 10.4244/EIJ-D-18-01073.

9.

Effects of Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester) on Atherogenic Lipid/Lipoprotein, Apolipoprotein, and Inflammatory Parameters in Patients With Elevated High-Sensitivity C-Reactive Protein (from the ANCHOR Study).

Miller M, Ballantyne CM, Bays HE, Granowitz C, Doyle RT Jr, Juliano RA, Philip S.

Am J Cardiol. 2019 Sep 1;124(5):696-701. doi: 10.1016/j.amjcard.2019.05.057. Epub 2019 Jun 6.

10.

Effect of supplementation with omega-3 fatty acids on hypertriglyceridemia in pediatric patients with obesity.

Del-Río-Navarro BE, Miranda-Lora AL, Huang F, Hall-Mondragon MS, Leija-Martínez JJ.

J Pediatr Endocrinol Metab. 2019 Aug 27;32(8):811-819. doi: 10.1515/jpem-2018-0409.

PMID:
31271554
11.

Clinical Efficacy and Biological Regulations of ω-3 PUFA-Derived Endocannabinoids in Major Depressive Disorder.

Yang B, Lin L, Bazinet RP, Chien YC, Chang JP, Satyanarayanan SK, Su H, Su KP.

Psychother Psychosom. 2019;88(4):215-224. doi: 10.1159/000501158. Epub 2019 Jul 3.

PMID:
31269506
12.

Camelina sativa Oil, Fatty Fish, and Lean Fish Do Not Markedly Affect Urinary Prostanoids in Subjects with Impaired Glucose Metabolism.

Erkkilä AT, Lee JC, Lankinen M, Manninen S, Leung HH, Oger C, de Mello VD, Schwab US.

Lipids. 2019 Aug;54(8):453-464. doi: 10.1002/lipd.12176. Epub 2019 Jul 1.

PMID:
31257613
13.

Compound-specific isotope analysis reveals no retroconversion of DHA to EPA but substantial conversion of EPA to DHA following supplementation: a randomized control trial.

Metherel AH, Irfan M, Klingel SL, Mutch DM, Bazinet RP.

Am J Clin Nutr. 2019 Oct 1;110(4):823-831. doi: 10.1093/ajcn/nqz097.

PMID:
31204771
14.

Effects of omega-3 fatty acids supplementation on neoadjuvant chemotherapy-induced toxicity in patients with locally advanced breast cancer: a randomized, controlled, double-blinded clinical trial.

de la Rosa Oliva F, Meneses García A, Ruiz Calzada H, Astudillo de la Vega H, Bargalló Rocha E, Lara-Medina F, Alvarado Miranda A, Matus-Santos J, Flores-Díaz D, Oñate-Acuña LF, Gutiérrez-Salmeán G, Ruiz García E, Ibarra A.

Nutr Hosp. 2019 Aug 26;36(4):769-776. doi: 10.20960/nh.2338.

15.

A comparison between the effects of flaxseed oil and fish oil supplementation on cardiovascular health in type 2 diabetic patients with coronary heart disease: A randomized, double-blinded, placebo-controlled trial.

Raygan F, Taghizadeh M, Mirhosseini N, Akbari E, Bahmani F, Memarzadeh MR, Sharifi N, Jafarnejad S, Banikazemi Z, Asemi Z.

Phytother Res. 2019 Jul;33(7):1943-1951. doi: 10.1002/ptr.6393. Epub 2019 Jun 13.

PMID:
31190359
16.

Impact of Dry Eye on Visual Acuity and Contrast Sensitivity: Dry Eye Assessment and Management Study.

Szczotka-Flynn LB, Maguire MG, Ying GS, Lin MC, Bunya VY, Dana R, Asbell PA; Dry Eye Assessment and Management (DREAM) Study Research Group.

Optom Vis Sci. 2019 Jun;96(6):387-396. doi: 10.1097/OPX.0000000000001387.

PMID:
31116166
17.

An increase in plasma brain derived neurotrophic factor levels is related to n-3 polyunsaturated fatty acid efficacy in first episode schizophrenia: secondary outcome analysis of the OFFER randomized clinical trial.

Pawełczyk T, Grancow-Grabka M, Trafalska E, Szemraj J, Żurner N, Pawełczyk A.

Psychopharmacology (Berl). 2019 Sep;236(9):2811-2822. doi: 10.1007/s00213-019-05258-4. Epub 2019 May 17.

18.

Docosahexaenoic acid supplementation of preterm infants and parent-reported symptoms of allergic disease at 7 years corrected age: follow-up of a randomized controlled trial.

Gunaratne AW, Makrides M, Collins CT, Gibson RA, McPhee AJ, Sullivan TR, Gould JF, Green TJ, Doyle LW, Davis PG, French NP, Colditz PB, Simmer K, Morris SA, Best KP.

Am J Clin Nutr. 2019 Jun 1;109(6):1600-1610. doi: 10.1093/ajcn/nqz010.

PMID:
31070712
19.

A combination of omega-3 and plant sterols regulate glucose and lipid metabolism in individuals with impaired glucose regulation: a randomized and controlled clinical trial.

Wang JF, Zhang HM, Li YY, Xia S, Wei Y, Yang L, Wang D, Ye JJ, Li HX, Yuan J, Pan RR.

Lipids Health Dis. 2019 May 1;18(1):106. doi: 10.1186/s12944-019-1048-x. Erratum in: Lipids Health Dis. 2020 Mar 16;19(1):41.

20.

Plasma oxylipins respond in a linear dose-response manner with increased intake of EPA and DHA: results from a randomized controlled trial in healthy humans.

Ostermann AI, West AL, Schoenfeld K, Browning LM, Walker CG, Jebb SA, Calder PC, Schebb NH.

Am J Clin Nutr. 2019 May 1;109(5):1251-1263. doi: 10.1093/ajcn/nqz016.

PMID:
31006007

Supplemental Content

Loading ...
Support Center